CNS Pharmaceuticals, Inc.
CNSP
$5.78
-$0.16-2.69%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
ACCESS Newswire
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
8/27/2026
-
ACCESS Newswire
8/27/2026
-
ACCESS Newswire
8/17/2026
-
TipRanks: TheFly
8/17/2026
-
TipRanks: TheFly
8/12/2026
-
ACCESS Newswire
7/21/2026
-
The Cerbat Gem
7/2/2026
-
TipRanks
6/11/2026
-
The Cerbat Gem
6/8/2026
-
ACCESS Newswire
5/20/2026
-
ACCESS Newswire
5/14/2026
-
24/7 Wall St.
5/6/2026
-
Benzinga
5/6/2026
-
The Cerbat Gem
5/5/2026
-
TipRanks Financial Blog
5/4/2026
-
MarketBeat
5/4/2026
-
The Cerbat Gem
5/4/2026
-
MarketBeat
5/4/2026
-
MarketBeat
5/4/2026
-
RTT News - Momentum Stocks
5/4/2026
-
Benzinga
5/4/2026
-
ACCESS Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 12, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
800 946 9185
Address
2100 West Loop South
Suite 900
Houston, TX 77027
Suite 900
Houston, TX 77027
Country
Year Founded
Business Description
Sector
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an...
more